LevothyroxineSodiumQualityChecker
Levothyroxine Sodium
Levothyroxine Sodium Quality Checker — Thyroid Hormone (Ph. Eur., USP)
ℹ️ The utility checks assay, specific rotation, D-thyroxine (toxic), T3, content uniformity.
ℹ️ Does not use machine learning — rule-based logic only.
⚠️ CRITICAL! D-Thyroxine ≤0.5%. Content Uniformity (CU) strict. Specific Rotation -14..-18°!
Usage:
LevothyroxineSodiumQualityChecker.exe → demo mode
LevothyroxineSodiumQualityChecker.exe input.csv output.json → evaluate data
Input format:
BatchNumber,Assay_Percent,Specific_Rotation,Liothyronine_Percent,Iodide_Percent,D_Thyroxine_Percent,Total_Impurities_Percent,Loss_On_Drying_Percent,Heavy_Metals_ppm,Content_Uniformity_RSD,Individual_Unit_Min_Percent,Individual_Unit_Max_Percent,Dissolution_45min_Percent,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected
Example:
LEVO-T4-2026-001,99.2,-16.5,0.1,0.1,0.05,0.3,0.5,8,4.5,90.0,110.0,92.0,20,5,0,0
— WHY IS THIS NEEDED?
Levothyroxine Sodium — synthetic thyroid hormone (T4):
• Used in micro-doses (mcg), so Content Uniformity is critical. Slight deviation leads to thyrotoxicosis or hypothyroidism.
• Enantiomeric Purity: D-thyroxine (dextrorotatory isomer) is cardiotoxic and must not be present. Specific rotation is strictly controlled.
• Liothyronine (T3) Impurity: More potent hormone, presence may cause unpredictable effects.
• Drug is unstable to light and heat, requires strict storage control.
⚠️ CRITICAL:
• Assay: 97–102%
• Specific Rotation: -18.0° to -14.0° (strictly for L-isomer)
• D-Thyroxine: ≤ 0.5% (toxic enantiomer)
• Liothyronine (T3): ≤ 0.5%
• Content Uniformity (RSD): ≤ 6.0%
• Dissolution: ≥ 80% in 45 min
• Microbiology: standard limits
⚠️ Note: Utility focuses on chiral purity and dose uniformity. Presence of D-thyroxine is a critical safety defect. Low content uniformity is unacceptable due to narrow therapeutic window. T3 control important to prevent hyperthyroid effects.
input.csv
BatchNumber,Assay_Percent,Specific_Rotation,Liothyronine_Percent,Iodide_Percent,D_Thyroxine_Percent,Total_Impurities_Percent,Loss_On_Drying_Percent,Heavy_Metals_ppm,Content_Uniformity_RSD,Individual_Unit_Min_Percent,Individual_Unit_Max_Percent,Dissolution_45min_Percent,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected LEVO-T4-2026-001,99.2,-16.5,0.1,0.1,0.05,0.3,0.5,8,4.5,90.0,110.0,92.0,20,5,0,0
URS & FS — user requirements and functional specification
This document defines user requirements and functional specification for the quality-control utility. It supports deployment discussion, IQ/OQ preparation and QC workflow integration.
1. Scope
The Levothyroxine Sodium Quality Checker utility is used for Levothyroxine Sodium. The actual input.csv is the source of truth for the input structure; control criteria are defined by the executable and the domain description.
The utility does not use machine learning; decisions are produced by deterministic rules.
Categories: Global API
Tags: API, assay, biosimilars, dissolution, fixed-dose combinations, generics, impurities, market map, microbiology, uniformity
2. Execution modes
LevothyroxineSodiumQualityChecker.exe → demo mode LevothyroxineSodiumQualityChecker.exe input.csv output.json → evaluate data
3. Key controlled areas
- assay / content
- dissolution / disintegration
- microbiology and pathogens
- heavy metals / elemental impurities
4. Domain limits and critical parameters
- ⚠️ CRITICAL! D-Thyroxine ≤0.5%. Content Uniformity (CU) strict. Specific Rotation -14..-18°!
- ⚠️ CRITICAL:
- Assay: 97–102%
- Specific Rotation: -18.0° to -14.0° (strictly for L-isomer)
- D-Thyroxine: ≤ 0.5% (toxic enantiomer)
- Liothyronine (T3): ≤ 0.5%
- Content Uniformity (RSD): ≤ 6.0%
- Dissolution: ≥ 80% in 45 min
- Microbiology: standard limits
- ⚠️ Note: Utility focuses on chiral purity and dose uniformity. Presence of D-thyroxine is a critical safety defect. Low content uniformity is unacceptable due to narrow therapeutic window. T3 control important to prevent hyperthyroid effects.
5. URS — user requirements
| ID | Requirement | Criticality | Acceptance criterion |
|---|---|---|---|
| URS-001 | The system shall accept an input.csv file for Levothyroxine Sodium with the exact columns listed in the “Input data contract” section. | High | A file with the correct header is processed without manual editing; missing mandatory columns produce FAIL/import error. |
| URS-002 | The system shall support execution without arguments in demo mode and execution with input.csv output.json for user data. | Medium | Both execution scenarios produce a predictable result or clear diagnostic error. |
| URS-003 | The system shall perform rule-based controls for: assay / content, dissolution / disintegration, microbiology and pathogens, heavy metals / elemental impurities. | High | Each controlled parameter receives a status and message; the result does not depend on hidden Excel formulas or ML. |
| URS-004 | The system shall preserve traceability between batch/lot, source values, applied rules and final verdict. | High | Output includes batch identifier, source values, parameter statuses and critical findings. |
| URS-005 | The system shall generate machine-readable output.json for LIMS/ELN/MES, batch record and QA/QC review. | High | JSON contains overall status, check array, warnings, failures and source-file reference. |
| URS-006 | The system shall support use in the client validation package: URS/FS, IQ/OQ preparation, installation and operational scenario checks. | High | The document, test scenarios and reproducible CSV/JSON flow are suitable for audit and internal approval. |
| URS-007 | The system shall clearly separate technical data errors from specification nonconformities. | Medium | Schema/type errors are not mixed with pharmacopoeial deviations and are reported separately. |
6. input.csv data contract
The source of truth for the input schema is the actual input.csv header. Column names are technical identifiers and are not translated.
| # | Column | Type | Unit | Description | Sample | Control rule |
|---|---|---|---|---|---|---|
| 1 | BatchNumber | identifier | as specified | Batch Number | LEVO-T4-2026-001 | mandatory field; used for batch/lot traceability |
| 2 | Assay_Percent | decimal | % | Assay % | 99.2 | numeric value; compared with assay/purity limit from specification or method |
| 3 | Specific_Rotation | decimal | as specified | Specific Rotation | -16.5 | mandatory numeric value; rule comparison is performed by the utility |
| 4 | Liothyronine_Percent | decimal | % | Liothyronine % | 0.1 | mandatory numeric value; rule comparison is performed by the utility |
| 5 | Iodide_Percent | decimal | % | Iodide % | 0.1 | mandatory numeric value; rule comparison is performed by the utility |
| 6 | D_Thyroxine_Percent | decimal | % | D Thyroxine % | 0.05 | mandatory numeric value; rule comparison is performed by the utility |
| 7 | Total_Impurities_Percent | decimal | % | Total Impurities % | 0.3 | mandatory numeric value; rule comparison is performed by the utility |
| 8 | Loss_On_Drying_Percent | decimal | % | Loss On Drying % | 0.5 | mandatory numeric value; rule comparison is performed by the utility |
| 9 | Heavy_Metals_ppm | decimal | ppm | Heavy Metals ppm | 8 | numeric value; checked as elemental/metal impurity |
| 10 | Content_Uniformity_RSD | decimal | as specified | Content Uniformity RSD | 4.5 | numeric value; compared with assay/purity limit from specification or method |
| 11 | Individual_Unit_Min_Percent | decimal | % | Individual Unit Min % | 90.0 | mandatory numeric value; rule comparison is performed by the utility |
| 12 | Individual_Unit_Max_Percent | decimal | % | Individual Unit Max % | 110.0 | mandatory numeric value; rule comparison is performed by the utility |
| 13 | Dissolution_45min_Percent | decimal | % | Dissolution 45min % | 92.0 | numeric value; dissolution/disintegration profile checked according to method |
| 14 | Microbial_Count_TAMC | decimal | as specified | Microbial Count TAMC | 20 | numeric value; compared with microbiological limits |
| 15 | Microbial_Count_TYMC | decimal | as specified | Microbial Count TYMC | 5 | numeric value; compared with microbiological limits |
| 16 | EColi_Detected | boolean / flag | 0/1 | EColi Detected | 0 | valid flag required; prohibited organisms and growth are normally expected as 0 / absent |
| 17 | Salmonella_Detected | boolean / flag | 0/1 | Salmonella Detected | 0 | valid flag required; prohibited organisms and growth are normally expected as 0 / absent |
CSV example
BatchNumber,Assay_Percent,Specific_Rotation,Liothyronine_Percent,Iodide_Percent,D_Thyroxine_Percent,Total_Impurities_Percent,Loss_On_Drying_Percent,Heavy_Metals_ppm,Content_Uniformity_RSD,Individual_Unit_Min_Percent,Individual_Unit_Max_Percent,Dissolution_45min_Percent,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected LEVO-T4-2026-001,99.2,-16.5,0.1,0.1,0.05,0.3,0.5,8,4.5,90.0,110.0,92.0,20,5,0,0
7. FS — functional specification
| ID | Function | Implementation description |
|---|---|---|
| FS-001 | CLI entry point | The executable LevothyroxineSodiumQualityChecker.exe supports demo mode and input.csv output.json processing mode. |
| FS-002 | CSV parser | The import module reads CSV, validates header, column presence/order, value count and encoding. Decimal values are expected with a dot separator. |
| FS-003 | Field conversion | Each column is converted to the expected type: identifier, text, decimal number, date/time or boolean flag. |
| FS-004 | Domain rule engine | For Levothyroxine Sodium, explicit rules are applied: range, minimum, maximum, absence of prohibited flag, data completeness or calculation-based check. |
| FS-005 | Criticality handling | Critical violations produce FAIL; non-critical deviations and incomplete data produce WARNING; full conformance produces PASS. |
| FS-006 | JSON writer | output.json stores overall status, per-parameter results, source values, warnings, failures and diagnostic messages. |
| FS-007 | Integration contract | The CSV → JSON format is stable for invocation from LIMS/ELN/MES, scheduled task or wrapper service. |
| FS-008 | Error handling | Schema error, missing file, non-numeric value or JSON write failure returns diagnosable error without silent PASS. |
8. output.json contract
The output file must be suitable for automated processing, audit review and correlation with the source input.csv row.
{
"utility": "LevothyroxineSodiumQualityChecker",
"api": "Levothyroxine Sodium",
"batchNumber": "LEVO-T4-2026-001",
"overallStatus": "PASS|WARNING|FAIL",
"checkedAtUtc": "2026-05-18T00:00:00Z",
"checks": [
{
"parameter": "BatchNumber",
"value": "LEVO-T4-2026-001",
"unit": "as specified",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Assay_Percent",
"value": "99.2",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Specific_Rotation",
"value": "-16.5",
"unit": "as specified",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Liothyronine_Percent",
"value": "0.1",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Iodide_Percent",
"value": "0.1",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "D_Thyroxine_Percent",
"value": "0.05",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Total_Impurities_Percent",
"value": "0.3",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Loss_On_Drying_Percent",
"value": "0.5",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
}
],
"criticalFindings": [],
"sourceFile": "input.csv"
}9. OQ/PQ test scenarios
| ID | Scenario | Expected result |
|---|---|---|
| TC-001 | Valid CSV with expected header and sample row | All rows are processed; output contains PASS/WARNING/FAIL and parameter-level detail. |
| TC-002 | A mandatory input.csv column is missing | Import is rejected or the row receives FAIL with schema reference. |
| TC-003 | A numeric field contains text or a blank value | Type conversion error is recorded; the result is not hidden as PASS. |
| TC-004 | A parameter is outside specification or critical limit | Critical parameters produce FAIL; non-critical deviations produce WARNING according to the rule. |
| TC-005 | Positive pathogen/microbiological flag or microbiological limit excursion | Critical FAIL is produced with the offending parameter. |
| TC-006 | Insufficient dissolution or excessive disintegration time | FAIL/WARNING is produced according to method criticality. |
10. QA/QC, CSV and change control
- Before production use, the client records executable version, checksum, specification/monograph version, test CSV, expected JSON and IQ/OQ results.
- Column names must not be changed without updating the validator and test scenarios.
- The source CSV, output.json and utility version should be stored together as an evidence package.
- Any change in control rules must go through change control and repeated OQ scenario verification.
Included in packages
Algeria: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenArgentina: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenAustralia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenBangladesh: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenBrazil: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenCanada: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenChina: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenColombia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenDemocratic Republic of the Congo: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenEgypt: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenEndocrinology QC Suite
QC package for endocrinology: thyroid, pituitary/peptide hormones, corticosteroids, sex hormones and selected metabolic medicines.
OpenEthiopia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenFrance: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenGermany: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenGlobal API & Biosimilars QC Suite
Package for high-demand global APIs, generics and biosimilars, including fixed-dose combinations and biological products.
OpenIndia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenIndonesia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenIran: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenItaly: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenJapan: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenKenya: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenMexico: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenMyanmar: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenNigeria: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenPakistan: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenPhilippines: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenRussia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSaudi Arabia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSouth Africa: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSouth Korea: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSudan: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenTanzania: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenThailand: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenTurkey: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenUganda: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenUnited Kingdom: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenUnited States: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenVietnam: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Open